RASGRF1 and bipolar disorder: Consistently, it has been shown that Rasgrf1 knockdown reversed the effect of UCMS on mice [140], and it has been shown in humans that RASGRF1 may be a potential specific biomarker of treatment response for bipolar disorder [141].